Evidence map›Paper›PMID 40160987›Full record

ArticleMolecular & cellular toxicology2025

Overview of the hazardous impacts of metabolism-disrupting chemicals on the progression of fatty liver diseases.

Garam An, Jisoo Song, Wei Ying, Whasun Lim

Abstract read
In one paragraph

Article in Molecular & cellular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Effects ofJournal of microbiology and biotechnology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Garam An *Department of Biological Sciences, Institute of Basic Science, College of Science, Sungkyunkwan University, Suwon, 16419 Republic of Korea.
Jisoo Song *Department of Biological Sciences, Institute of Basic Science, College of Science, Sungkyunkwan University, Suwon, 16419 Republic of Korea.
Wei YingDivision of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA 92093 USA.
Whasun LimDepartment of Biological Sciences, Institute of Basic Science, College of Science, Sungkyunkwan University, Suwon, 16419 Republic of Korea.ORCID 0000-0002-1328-0465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Given the global increase in obesity, metabolic dysfunction-associated steatotic liver disease (MASLD) is a major health concern. Because the liver is the primary organ for xenobiotic metabolism, the impact of environmental stressors on liver homeostasis and MASLD has garnered significant interest over the past few decades. The concept of metabolism-disrupting chemicals (MDCs) has been introduced to underscore the importance of environmental factors in metabolic homeostasis. Recent epidemiological and biological studies suggest a causal link between exposure to MDCs and prevalence and progression of MASLD. Objective: This review aims to introduce the emerging concept of MDCs and their representative toxic mechanisms. In particular, this review focuses on broadening the understanding of their impacts on MASLD or metabolic dysfunction-associated steatohepatitis (MASH) progression. Result: Recent research has highlighted the environmental contaminants, such as heavy metals, microplastics, and pesticides, have the potential to influence hepatic metabolism and aggravate MASLD/MASH progression. These MDCs not only directly affect lipid metabolism in hepatocytes but also affect other cell types, such as immune cells and stellate cells, as well as the gut-liver axis. Conclusion: Collectively, these findings contribute to establishing a well-defined adverse outcome pathway and identify novel therapeutic options for liver diseases associated with pollutants.

Indexed as

HepatocytesMetabolic-associated steatohepatitisMetabolic dysfunction-associated steatotic liver diseasesMetabolism-disrupting chemicals

Identifiers

PMID40160987
PMCPMC11947047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.